For the Inventor, By the Inventor

Enter assignee name

Institut Curie

Patents = 154

Trademarks = 5

Forward Citations = 516

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

543 inventors (with patents filed for the assignee):

Jamal Tazi (38 out of 38 patents)

Didier Scherrer (31 out of 34 patents)

Romain Najman (30 out of 30 patents)

4. Florence Mahuteau (22 out of 22 patents)

5. Marie Dutreix (14 out of 14 patents)

6. David Grierson (14 out of 18 patents)

7. Jean-Louis Viovy (12 out of 23 patents)

8. Pierre Roux (12 out of 17 patents)

9. Aude Garcel (11 out of 11 patents)

10. Jian-Sheng Sun (11 out of 11 patents)

11. Florence Mahuteau-Betzer (9 out of 9 patents)

12. Sebastian Amigorena (8 out of 11 patents)

13. Franck Perez (8 out of 9 patents)

14. Julien Santo (8 out of 8 patents)

15. Ludger Johannes (8 out of 12 patents)

154 patents: Sort by Forward Citations

1. 12479802 - Phenyl-n-quinoline derivatives for treating a RNA virus infection (2025-11-25),

2. 12421206 - Aryl-n-aryl derivatives for treating a RNA virus infection (2025-09-23),

3. 12415781 - Compounds with biguanidyl radical and uses thereof (2025-09-16),

4. 12414991 - Azobenzene derivatives, process for their preparation and their use for therapeutic treatment associated with ionizing radiations (2025-09-16),

5. 12371741 - Method for detecting a mutation in a microsatellite sequence (2025-07-29),

6. 12371471 - Immune cells defective for SUV39H1 (2025-07-29),

7. 12308126 - Device and method for predicting a relapse of a cancer for a patient (2025-05-20),

8. 12300356 - Cell-free detection of methylated tumour DNA (2025-05-13),

9. 12252517 - Hook fusion protein for regulating the cellular trafficking of a target protein (2025-03-18),

10. 12247018 - Aryl-n-aryl derivatives for treating a RNA virus infection (2025-03-11),

11. 12202804 - In vitro or ex vivo methods for screening a quinoline derivative (2025-01-21),

12. 12152077 - Immunotherapy targeting tumor neoantigenic peptides (2024-11-26),

13. 12084422 - Phenyl-n-quinoline derivatives for treating a RNA virus infection (2024-09-10),

14. 11992499 - Quinoline derivatives for use in the treatment of inflammation diseases (2024-05-28),

15. 11866484 - Synthetic single domain antibody (2024-01-09),

The Institut Curie is a leading French research center in oncology. Founded in 1909, the institute is named after Marie Curie, the renowned physicist and chemist who conducted groundbreaking research on radioactivity. Institut Curie focuses on cancer research, treatment, and care, with a multidisciplinary approach that includes biology, genetics, physics, and medicine. Today, Institut Curie is internationally recognized for its contributions to cancer research and its commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

154 Patents

#47 in

#176 in

#5,171 in the World

Institut Curie

Forward Citations = 516

543 inventors:

Jamal Tazi (38 out of 38 patents)

Didier Scherrer (31 out of 34 patents)

Romain Najman (30 out of 30 patents)

4. Florence Mahuteau (22 out of 22 patents)

5. Marie Dutreix (14 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…